What is Quoin Pharmaceuticals Ltd - ADR Annual Net Profit?

Quoin Pharmaceuticals Ltd - ADR Annual Net Profit fell 3.18% in the last year to $8.96 M. Its sector's average net profit growth for the last fiscal year was -32.48%.

What is Quoin Pharmaceuticals Ltd - ADR Price to Earning Ratio?

Quoin Pharmaceuticals Ltd - ADR Price to Earning Ratio is -0.43, which is negative.

What is Quoin Pharmaceuticals Ltd - ADR Stock Price?

Quoin Pharmaceuticals Ltd - ADR Stock Price fell 98.58% and underperformed its sector by 108.92% in the past year.

What is Quoin Pharmaceuticals Ltd - ADR Quarterly Net profit?

Quoin Pharmaceuticals Ltd - ADR Quarterly Net profit fell 12.75% YoY to $2.31 M. Its sector's average net profit growth YoY for the quarter was -42%.

What is Quoin Pharmaceuticals Ltd - ADR Return on Equity(ROE)?

Quoin Pharmaceuticals Ltd - ADR Return on Equity(ROE) for the last financial year was -120.56%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Quoin Pharmaceuticals Ltd - ADR Mutual Fund Holding?

Quoin Pharmaceuticals Ltd - ADR Mutual Fund Holding remained the same in the last quarter at 0%.

What is Quoin Pharmaceuticals Ltd - ADR Institutional Holding?

Quoin Pharmaceuticals Ltd - ADR Institutional Holding increased by 0.09% in the last quarter to 7.6.

How is the Quoin Pharmaceuticals Ltd - ADR today?

The Quoin Pharmaceuticals Ltd - ADR today is trading in the green, up by 9.33% at 6.56.

How has Quoin Pharmaceuticals Ltd - ADR performed historically?

The Quoin Pharmaceuticals Ltd - ADR is currently trading up 9.33% on an intraday basis in the past week the index rose 9.33%. The index has been down -97.72% in the past quarter and fell -98.58% in the past year. You can view this in the overview section.

Quoin Pharmaceuticals Ltd - ADR XNAS: QNRX

Quoin Pharmaceuticals Ltd - ADR Live Share Price Today, Share Analysis and Chart

Name: Quoin Pharmaceuticals Ltd - ADR: Is Infosys Ltd. worth buying?
Item: Quoin Pharmaceuticals Ltd - ADR
Rating: 0.51400
Author: Trendlyne DVM scores

Download real time

6.56 0.56 (9.33%)

99.40% Fall from 52W High

38,121 XNAS Volume

XNAS 23 Apr, 2025 5:30 PM (EDT)

Quoin Pharmaceuticals Ltd ... Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	3.9
PE TTM Negative PE TTM Unavailable in chosen country	-0.4
PEG TTM Below industry Median Unavailable in chosen country	0.1
Price to Book Below industry Median Unavailable in chosen country	0.4
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	7.6
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-12.8
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-3.2
Piotroski Score Low in industry Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	-97.9
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-120.6
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-64.3

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

14.5 / 100

Technically Bearish

6.1 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Quoin Pharmaceuticals Ltd ... Stock Price Analysis

Day Price Range 9.3% 1 Day return Unavailable in chosen country	6.6 (LTP) 5.86.9 LowHigh
Week Price Range 9.3% 1 Week return Unavailable in chosen country	6.6 (LTP) 5.36.9 LowHigh
Month Price Range -96.9% 1 Month return Unavailable in chosen country	6.6 (LTP) 5294 LowHigh
52 Week Price Range -98.6% 1 Year return Unavailable in chosen country	6.6 (LTP) 51,099 LowHigh

View full Share Price History

Quoin Pharmaceuticals Ltd ... Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Quoin Pharmaceuticals Ltd ... Stock Analysis

Quoin Pharmaceuticals Ltd ... stock analysis with key metrics, changes, and trends.

Quoin Pharmaceuticals Ltd ... Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$8.96 M	3.18%	negative	Annual Net Profit fell 3.18% in the last year to $8.96 M. Its sector's average net profit growth for the last fiscal year was -32.48%.
Price to Earning Ratio	-0.43	-	negative	Price to Earning Ratio is -0.43, which is negative.
Stock Price	$6.56	-98.58%	negative	Stock Price fell 98.58% and underperformed its sector by 108.92% in the past year.
Quarterly Net profit	$2.31 M	12.75%	negative	Quarterly Net profit fell 12.75% YoY to $2.31 M. Its sector's average net profit growth YoY for the quarter was -42%.
Return on Equity(ROE)	-120.56 %	-120.56%	negative	Return on Equity(ROE) for the last financial year was -120.56%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	0.00 %	0%	neutral	Mutual Fund Holding remained the same in the last quarter at 0%.
Institutional Holding	7.60 %	0.09%	positive	Institutional Holding increased by 0.09% in the last quarter to 7.6.

VIEW LESS

Loading data..

Quoin Pharmaceuticals Ltd - ADR - Company Profile

What does Quoin Pharmaceuticals Ltd - ADR do?

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Gross Remuneration

2024

Gross Remuneration

Year

Quoin Pharmaceuticals Ltd - ADR Live Share Price Today, Share Analysis and Chart

99.40% Fall from 52W High

Quoin Pharmaceuticals Ltd ... Key Metrics

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Quoin Pharmaceuticals Ltd ... Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Quoin Pharmaceuticals Ltd ... Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Quoin Pharmaceuticals Ltd ... Stock Analysis

Quoin Pharmaceuticals Ltd ... stock analysis with key metrics, changes, and trends.

Annual Net Profit fell 3.18% in the last year to $8.96 M. Its sector's average net profit growth for the last fiscal year was -32.48%.

Price to Earning Ratio is -0.43, which is negative.

Stock Price fell 98.58% and underperformed its sector by 108.92% in the past year.

Quarterly Net profit fell 12.75% YoY to $2.31 M. Its sector's average net profit growth YoY for the quarter was -42%.

Return on Equity(ROE) for the last financial year was -120.56%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding remained the same in the last quarter at 0%.

Institutional Holding increased by 0.09% in the last quarter to 7.6.

Quoin Pharmaceuticals Ltd - ADR - Company Profile

What does Quoin Pharmaceuticals Ltd - ADR do?

Quoin Pharmaceuticals Ltd - ADR Management structure

Mr. Gordon Dunn

Chief Financial Officer and Principal Accounting Officer

Dr. Michael Myers, PhD

Chairman of the Board and Chief Executive Officer

Ms. Denise Carter

Director and Chief Operating Officer

Quoin Pharmaceuticals Ltd - ADR Board of directors

Dr. Dennis H. Langer, J.D.,M.D.

Independent Director

Mr. Joseph P. Cooper

Independent Director

Mr. Anthony James Culverwell

Independent Director

Dr. Michael Myers, PhD

Chairman of the Board and Chief Executive Officer

Ms. Denise Carter

Director and Chief Operating Officer

Ms. Natalie Leong

Independent Director

Quoin Pharmaceuticals Ltd - ADR FAQ

How is Quoin Pharmaceuticals Ltd - ADR today?

Quoin Pharmaceuticals Ltd - ADR today is trading in the green, and is up by 9.33% at 6.56.

How has Quoin Pharmaceuticals Ltd - ADR performed historically?

Quoin Pharmaceuticals Ltd - ADR is currently trading up 9.33% on an intraday basis. In the past week the stock rose 9.33%. stock has been down -97.72% in the past quarter and fell -98.58% in the past year. You can view this in the overview section.